Cargando…

Altered levels of cytokines in patients with irritable bowel syndrome are not correlated with fatigue

INTRODUCTION: A considerable number of patients with gastrointestinal complaints attributable to irritable bowel syndrome (IBS) have shown evidence of immune activation. Fatigue is also frequently reported by IBS patients and the condition is considered as a common comorbidity of IBS. Therefore, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vara, Ellen Johanne, Brokstad, Karl A, Hausken, Trygve, Lied, Gülen Arslan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038856/ https://www.ncbi.nlm.nih.gov/pubmed/30013383 http://dx.doi.org/10.2147/IJGM.S166600

Ejemplares similares

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
por: Mazzawi, Tarek, et al.
Publicado: (2022)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives
por: FJELDHEIM DALE, Hanna, et al.
Publicado: (2020)

Assessment of Self-Reported Executive Function in Patients with Irritable Bowel Syndrome Using a Machine-Learning Framework
por: Lundervold, Astri J., et al.
Publicado: (2023)

Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome
por: Hillestad, Eline Margrete Randulff, et al.
Publicado: (2022)

Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

A psychological symptom based machine learning model for clinical evaluation of irritable bowel syndrome
por: Haleem, Noman, et al.
Publicado: (2023)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Stomach antral endocrine cells in patients with irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2018)

Effect of a cod protein hydrolysate on postprandial glucose metabolism in healthy subjects: a double-blind cross-over trial — CORRIGENDUM
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Acute effect of a cod protein hydrolysate on postprandial acylated ghrelin concentration and sensations associated with appetite in healthy subjects: a double-blind crossover trial
por: Dale, Hanna Fjeldheim, et al.
Publicado: (2019)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Increased wall thickness using ultrasonography is associated with inflammation in an animal model of experimental colitis
por: Lied, Gülen Arslan, et al.
Publicado: (2012)

Supplementation with Low Doses of a Cod Protein Hydrolysate on Glucose Regulation and Lipid Metabolism in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study
por: Jensen, Caroline, et al.
Publicado: (2020)

The Effect of Supplementation with Low Doses of a Cod Protein Hydrolysate on Satiety Hormones and Inflammatory Biomarkers in Adults with Metabolic Syndrome: A Randomized, Double-Blind Study
por: Jensen, Caroline, et al.
Publicado: (2020)

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome
por: MAZZAWI, TAREK, et al.
Publicado: (2014)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors
por: Steinsvik, Elisabeth K, et al.
Publicado: (2020)

Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome
por: Berentsen, Birgitte, et al.
Publicado: (2020)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance
por: Mazzawi, Tarek, et al.
Publicado: (2015)

Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review)
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Prevalence of Irritable Bowel Syndrome in Chronic Fatigue
por: Gomborone, JE, et al.
Publicado: (1996)

Chromogranin A cell density in the rectum of patients with irritable bowel syndrome
por: EL-SALHY, M., et al.
Publicado: (2012)

Supplementation with cod protein hydrolysate in older adults: a dose range cross-over study
por: Jensen, Caroline, et al.
Publicado: (2019)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome
por: Mazzawi, T, et al.
Publicado: (2015)

Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report
por: El-Salhy, Magdy, et al.
Publicado: (2013)

Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome
por: GAO, JINGGUO
Publicado: (2013)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome
por: Mazzawi, T, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f112preri8ifc7fij5jtshlr6r